Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Adenoviral vectors induce robust epitope-specific CD8+ T cell responses. Within the repertoire of responses generated both conventional memory evolution and the phenomenon of memory inflation are seen. The rules governing which epitopes inflate are not fully known, but may include a role for both antigen processing and competition. To investigate this we looked at memory generated from vectors targeting the Gp33-41 (KAVYNFATC/K9C) epitope from the glycoprotein of Lymphocytic Choriomeningitis Virus (LCMV) in mice. This well described epitope has both the Gp33-41 and Gp34-41 epitopes embedded within it. Vaccination with a full-length glycoprotein (Gp) or a minigene Ad-Gp33/K9C vector induced conventional memory responses against the immunodominant Gp33/K9C epitope but a strong inflationary response against the Gp34/A8C epitope. These responses showed sustained in vivo function, with complete protection against LCMV infectious challenge. Given the unexpected competition between epitopes seen in the minigene model we further tested epitope competition using the full-length Ad-LacZ (β-galactosidase) model. Generation of an Ad-LacZ vector with a single amino acid disruption of the inflationary β-gal96-103 /D8V epitope transformed the β-gal497-504 /I8V epitope from conventional to inflationary memory. This work collectively demonstrates the importance of epitope competition within adenoviral vector inserts and is of relevance to future studies using adenoviral vectored immunogens. This article is protected by copyright. All rights reserved.

Original publication

DOI

10.1002/eji.201948143

Type

Journal article

Journal

European journal of immunology

Publication Date

20/05/2019

Addresses

Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, UK.